Brexanolone phase 3 trials report, Lancet 2018
The report of the two phase 3 trials of brexanolone injection for postpartum depression, published in The Lancet in 2018.
- Publication
- In this atlas
Overview
Technical summary
Lancet 2018;392(10152):1058-1070. doi:10.1016/S0140-6736(18)31551-4. PMID 30177236.
Bibliographic identity
- Type
- Article
- Source
- Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
- Edition
- PubMed record (abstract and bibliographic data) from NCBI E-utilities. The full text and the version of record were not fetched. PubMed lists a published erratum for this paper (PMID 30303081). PubMed holds no abstract for the erratum, and its text was not read, so any figure taken from this abstract is stated as printed in the abstract and may have been corrected.
- Publisher
- Lancet (London, England)
- Published
- 2018-09-22
Record details
- Record id
maternal:pub-brexanolone-lancet-2018- Content hash
9c32e69eee1dd60c263695f1fe9ad19532a0c50bf2ef8435cf982c22d693bbe1